Target intelligence / Profile preview

Ras-related protein Rap1 (Rap1 signaling pathway) (Rap1)

Target
Rap1
Molecular classification
Small GTPase, Signaling pathway, Ras superfamily
01

Overview

The Rap1 pathway refers to the intracellular signal transduction cascade centered on Ras-related protein 1 (Rap1), a small GTPase belonging to the Ras superfamily[5]. Rap1 functions as a molecular switch, cycling between inactive (GDP-bound) and active (GTP-bound) forms to regulate processes such as integrin-mediated cell adhesion, cell junction formation, cell migration, proliferation, and survival[5][3]. The pathway operates through Rap1's interactions with guanine nucleotide exchange factors (RapGEFs), GTPase-activating proteins (RapGAPs), and effectors such as RIAM and talin, impacting actin cytoskeleton and cellular motility[1][5]. Rap1 signaling can be oncogenic or tumor-suppressive depending on cellular context, with prominent roles in cancer metastasis, cardiovascular biology, and pancreatic beta-cell function[2][3][4][6]. The pathway has been proposed as a therapeutic target, but no selective drugs are approved, and safety concerns remain due to the broad systemic functions of this signaling cascade[6].

Other names
Rap1 pathwayRap1 signalingRas-proximate-1 pathwayRap1 signaling cascade
02

Mechanism of action

Inhibition of GTPase activity (potential for small molecule inhibitors) Modulation of RapGEF/RapGAP activity Interference with protein–protein interaction (e.g., Rap1–RIAM interaction[1])

03

Biological functions

Signal transductionCell adhesionCell proliferationCell migrationCell polarityApoptosis
04

Disease associations

Cancer (metastasis, invasion)Cardiovascular disease (vascular remodeling, vessel stiffness)Diabetes (beta cell proliferation, insulin secretion)Other: developmental defects, tissue morphogenesis
05

Safety considerations

Potential for broad effects on normal cellular adhesion, migration, and proliferation—on-target toxicity is a concern[6]Cardiovascular, developmental, and immune system side effects likely with systemic inhibition of core pathway components[6]
06

Interacting drugs

No FDA-approved drugs that directly target Rap1 are currently available. Some experimental inhibitors target pathway regulators (RapGEFs, RapGAPs) or downstream effectors, but none are established in clinical use[6][3].
07

Biomarkers

Rap1A/B expression/activity (as correlates in cancer and diabetes[2][4])Rap1GAP loss (biomarker of metastatic potential)

Beyond the preview

Go deeper on Ras-related protein Rap1 (Rap1 signaling pathway) (Rap1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rap1 (Rap1 signaling pathway) (Rap1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call